Ascentage Pharma Group International (OTCMKTS:ASPHF) Short Interest Up 21.1% in November

Ascentage Pharma Group International (OTCMKTS:ASPHF) was the target of a large growth in short interest in November. As of November 30th, there was short interest totalling 766,100 shares, a growth of 21.1% from the November 15th total of 632,500 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Ascentage Pharma Group International Stock Performance

Shares of ASPHF stock opened at $6.45 on Friday. The firm has a fifty day moving average price of $5.77 and a 200 day moving average price of $3.76. Ascentage Pharma Group International has a 12 month low of $6.45 and a 12 month high of $6.45.

About Ascentage Pharma Group International

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation.